1015 Capital Partners’s Versigent VGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1
Closed -$42 – 613
2026
Q2
$42 Buy
+1
New +$40 ﹤0.01% 609

Other funds holding VGNT

1015 Capital Partners's VGNT Position: Q3 2026 in Review

1015 Capital Partners sold out of Versigent (VGNT) in Q3 2026, closing a stake of 1 share — an estimated $42 sold.

1015 Capital Partners first reported a position in VGNT in Q2 2026 and held it in 1 quarter. The position peaked at $42 in Q2 2026. 444 funds tracked by Wall St. Rank hold VGNT as of Q3 2026.

  • 1015 Capital Partners reported no remaining Versigent position as of Q3 2026 after selling out during the quarter.
  • 1015 Capital Partners sold 1 Versigent share in Q3 2026, an estimated $42.
  • 1015 Capital Partners first reported a position in Versigent in Q2 2026 and held it in 1 quarter.
  • 1015 Capital Partners's Versigent position peaked at $42 in Q2 2026.
  • 444 funds tracked by Wall St. Rank held Versigent as of Q3 2026.

Based on 1015 Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.